EN | TR
E-ISSN: 2980-261X
Is Target Vessel and Device Diameter Important for Results in Peripheral Interventions for Femoropopliteal Artery Disease?
PDF
Cite
Share
Request
Original Research
VOLUME: 1 ISSUE: 2
P: 37-42
August 2023

Is Target Vessel and Device Diameter Important for Results in Peripheral Interventions for Femoropopliteal Artery Disease?

Bull Crdiov Acad 2023;1(2):37-42
DOI: 10.4274/kvbulten.galenos.2023.09709
İbrahim Çağrı Kaya 1
Halil Bulut 2
Alper Selim Kocaoğlu 1
1. Sağlık Bilimleri Üniversitesi, Eskişehir Şehir Sağlık Uygulama ve Araştırma Hastanesi, Kalp ve Damar Cerrahisi Kliniği, Eskişehir, Türkiye
2. İstanbul Üniversitesi-Cerrahpaşa, Cerrahpaşa Tıp Fakültesi, Kalp ve Damar Cerrahisi Anabilim Dalı, İstanbul, Türkiye
No information available.
No information available
Received Date: 12.07.2023
Accepted Date: 08.08.2023
Publish Date: 18.09.2023
PDF
Cite
Share
Request

ABSTRACT

Objective:

Peripheral arterial disease (PAH) is a common cardiovascular disease. PAH treatments are long-term treatments that target the control of risk factors. Endovascular treatment is considered a more comfortable option compared to surgery. In recent years, increasing evidence has emerged about the efficacy of endovascular treatment modalities. This study investigates the effect of device diameter on endovascular treatment outcomes in PAH.

Material and Methods:

In this retrospective cohort study, endovascular interventions on 100 patients were evaluated. The collected data was anonymized before being transferred to an electronic database for analysis. SPSS 26.0 was used for statistical analysis; chi-square, Fisher’s exact test and phi-crammer tests were used for categorical variables, while F-ANOVA test was used for continuous variables.

Results:

Based on the study’s findings, no significant difference was observed between the change in device diameter and factors such as female gender, age, coronary artery disease, hypertension, type 2 diabetes, and tobacco use. However, the rate of stenosis varied between different groups. Furthermore, there was no significant difference in outcomes between the use of drug-coated balloon angioplasty and bare metal stent applications. Both technical success rates and hemodynamic success rates were consistently high across all groups, with no statistically significant differences between them. Similarly, the primary patency rates remained notably high during both the 30-day and 6-month follow-up periods, showing no statistically significant variation.

Conclusion:

This study evaluated the effect of device diameter on endovascular treatment outcomes in PAH. Device diameters did not have any effect on revascularization, the results were high and promising in all groups. However, the limitations of the study and the lack of a randomized controlled design should be considered. Therefore, prospective studies with larger patient groups are needed.

Keywords:
Peripheral arterial disease, vessel diameter, stenosis

References

1
Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res 2015;116(9):1509-1526.
2
Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol 2022;19(7):456-474.
3
Kaya İÇ, Bulut Hİ, Özkan AH. Endovascular Treatment for Femoro-popliteal Artery Disease with Chronic Total Occlusions: Short-term Outcomes in Local State Hospital. Bulletin of Cardiovascular Academy 2023;1(1):12-16.
4
Turk Kardiyoloji Dernegi Girisimsel Kardiyolojide Yetkinlik Kilavuzu, https://tkd.org.tr/kilavuz/girisimsel_kilavuz.htm.
5
Stoner MC, Calligaro KD, Chaer RA, Dietzek AM, Farber A, Guzman RJ, et al. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg 2016;64(1):e1-e21.
6
Bethel M, Annex BH. Peripheral arterial disease: A small and large vessel problem. American Heart Journal Plus: Cardiology Research and Practice 2023;28:100291.
7
O’Connor NJ, Morton JR, Birkmeyer JD, Olmstead EM, O’Connor GT. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 1996;93(4):652-655.
8
 Walsh P, McLachlan C. Stenosis and Thrombosis. Wiley Encyclopedia of Biomedical Engineering. April 14, 2006.
9
Beckman JA, Schneider PA, Conte MS. Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD. Circ Res 2021;128(12):1885-1912.